Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts


  Free Subscription

Articles published in Int J Cardiol

Retrieve available abstracts of 35 articles:
HTML format
Text format

Single Articles

    November 2017
  1. LIN XL, Liu MH
    Statin and ezetimibe combination therapy: New therapeutic options for lowering Low-Density Lipoprotein Cholesterol.
    Int J Cardiol. 2017;247:49.
    PubMed     Text format    

    February 2017
  2. DUFOUR R, Bergeron J, Gaudet D, Weiss R, et al
    Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment.
    Int J Cardiol. 2017;228:754-760.
    PubMed     Text format     Abstract available

    January 2017
  3. LIN PY, Lee FY, Wallace CG, Chen KH, et al
    The therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced rabbit aortic atherosclerosis and stiffness.
    Int J Cardiol. 2017;227:938-949.
    PubMed     Text format     Abstract available

  4. HU D, Yang Y, Peng DQ
    Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
    Int J Cardiol. 2017;227:61-65.
    PubMed     Text format     Abstract available

  5. KISHIMOTO S, Kajikawa M, Maruhashi T, Iwamoto Y, et al
    Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(16)32405.
    PubMed     Text format     Abstract available

    November 2016
  6. KUWABARA M, Niwa K, Nishihara S, Nishi Y, et al
    Hyperuricemia is an independent competing risk factor for atrial fibrillation.
    Int J Cardiol. 2016 Nov 15. pii: S0167-5273(16)32841.
    PubMed     Text format     Abstract available

    August 2016
  7. BAEK YS, Yang PS, Kim TH, Uhm JS, et al
    Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome.
    Int J Cardiol. 2016;223:276-281.
    PubMed     Text format     Abstract available

  8. REYES EB, Ha JW, Firdaus I, Ghazi AM, et al
    Heart failure across Asia: Same healthcare burden but differences in organization of care.
    Int J Cardiol. 2016;223:163-167.
    PubMed     Text format     Abstract available

    July 2016
  9. MENDEZ-BAILON M, Munoz-Rivas N, Jimenez-Garcia R, Esteban-Hernandez J, et al
    Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004-2013).
    Int J Cardiol. 2016;221:688-694.
    PubMed     Text format     Abstract available

    June 2016
  10. SAHINER L, Asil S, Kaya EB, Ozer N, et al
    Percutaneous Implantation of the self-expanding valve Prosthesis a patient with homozygous familial hypercholesterolemia severe aortic stenosis and porcelain aorta.
    Int J Cardiol. 2016;220:661-664.
    PubMed     Text format     Abstract available

  11. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available

  12. WU AH, Gladden JD, Ahmed M, Ahmed A, et al
    Relation of serum uric acid to cardiovascular disease.
    Int J Cardiol. 2016;213:4-7.
    PubMed     Text format     Abstract available

    May 2016
  13. PLAKHT Y, Gilutz H, Shiyovich A
    Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project.
    Int J Cardiol. 2016;219:20-24.
    PubMed     Text format     Abstract available

    April 2016
  14. DI MINNO MN, Di Minno A, Ambrosino P, Songia P, et al
    Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis.
    Int J Cardiol. 2016;217:1-6.
    PubMed     Text format     Abstract available

    March 2016
  15. MASCITELLI L, Goldstein MR
    Might ezetimibe be considered an expensive placebo?
    Int J Cardiol. 2016;207:48-9.
    PubMed     Text format    

    January 2016
  16. FUENTES F, Alcala-Diaz JF, Watts GF, Mata P, et al
    Diabetes, statins and FH.
    Int J Cardiol. 2016;203:575.
    PubMed     Text format    

  17. NAKOU ES, Simantirakis EN, Kallergis EM, Skalidis EI, et al
    Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Int J Cardiol. 2016;203:432-3.
    PubMed     Text format    

  18. TANG L, Jiang L, Pan XD, Chen PP, et al
    Extremely severe aortic stenosis developed in a young female patient with underdiagnosis of homozygous familial hypercholesterolemia: An 8-year follow-up.
    Int J Cardiol. 2016;207:372-374.
    PubMed     Text format    

  19. FILIPPATOS TD, Elisaf MS
    Effects of ezetimibe/simvastatin combination on metabolic parameters.
    Int J Cardiol. 2016;202:273-4.
    PubMed     Text format    

  20. KOH KK, Oh PC, Sakuma I
    Reply to comment on: Effects of ezetimibe/simvastatin combination on metabolic parameters by Prof. Moses S Elisaf.
    Int J Cardiol. 2016;202:154-5.
    PubMed     Text format    

  21. YU Q, Su X, Liu E
    Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study.
    Int J Cardiol. 2016;202:954-5.
    PubMed     Text format    

  22. ZU L, Ren C, Pan B, Zhou B, et al
    Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells.
    Int J Cardiol. 2016;202:756-9.
    PubMed     Text format    

  23. OIKONOMOU E, Siasos G, Tousoulis D
    Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
    Int J Cardiol. 2016;202:586-8.
    PubMed     Text format    

    April 2015
  24. WATTS GF, Shaw JE, Pang J, Magliano DJ, et al
    Prevalence and treatment of familial hypercholesterolaemia in Australian communities.
    Int J Cardiol. 2015;185:69-71.
    PubMed     Text format    

  25. MACHADO VA, Fonseca FA, Fonseca HA, Malina DT, et al
    Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia.
    Int J Cardiol. 2015;184:570-2.
    PubMed     Text format    

    March 2015
  26. TOURNADRE A, Tatar Z, Pereira B, Chevreau M, et al
    Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.
    Int J Cardiol. 2015;183:149-54.
    PubMed     Text format     Abstract available

  27. RUBINSTEIN AL, Irazola VE, Calandrelli M, Elorriaga N, et al
    Multiple cardiometabolic risk factors in the Southern Cone of Latin America: a population-based study in Argentina, Chile, and Uruguay.
    Int J Cardiol. 2015;183:82-8.
    PubMed     Text format     Abstract available

  28. WEI Y, Guo H, The E, Che W, et al
    Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China.
    Int J Cardiol. 2015;182:469-75.
    PubMed     Text format     Abstract available

    February 2015
  29. CHEN CX, Hay JW
    Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Int J Cardiol. 2015;181:417-24.
    PubMed     Text format     Abstract available

    January 2015
  30. SHIH CH, Ou SY, Shih CJ, Chen YT, et al
    Bidirectional association between the risk of comorbidities and the diagnosis of retinal vein occlusion in an elderly population: a nationwide population-based study.
    Int J Cardiol. 2015;178:256-61.
    PubMed     Text format     Abstract available

  31. DE GONZALO-CALVO D, Llorente-Cortes V, Orbe J, Paramo JA, et al
    High triglyceride-low HDL cholesterol lipid profile is associated with a dysregulated gene expression in mononuclear leukocyte from hypercholesterolemic patients.
    Int J Cardiol. 2015;178:102-4.
    PubMed     Text format    

  32. HERMANNS MI, Grossmann V, Spronk HM, Schulz A, et al
    Distribution, genetic and cardiovascular determinants of FVIII:c - Data from the population-based Gutenberg Health Study.
    Int J Cardiol. 2015;187:166-74.
    PubMed     Text format     Abstract available

  33. KRINTUS M, Kozinski M, Boudry P, Lackner K, et al
    Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I.
    Int J Cardiol. 2015;187:256-63.
    PubMed     Text format     Abstract available

    September 2014
  34. ROTH EM, Taskinen MR, Ginsberg HN, Kastelein JJ, et al
    Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial.
    Int J Cardiol. 2014;176:55-61.
    PubMed     Text format     Abstract available

    July 2014
  35. ZHAO X, Bu L, Qin S, Kong D, et al
    Early development of xanthoma and coronary disease in a young female with homozygous familial hypercholesterolemia.
    Int J Cardiol. 2014 Jul 6. pii: S0167-5273(14)01170.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.